PAR:IPN

Ipsen S.A. · PAR · Healthcare · EUR · FY for 2025

Figures on this page computed 2026-11-08 13:05 UTC

Last close

n/aEUR

Market data

29.6xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed
- Computed from the filing for 2025
15.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
12.1%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
28.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.20Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.9%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed

Growth is the furthest below its sector's middle: 0.41 against 0.47 on the market's range.

All from 100

lens 2 of 9

Sales

220

2016-12-31 to 2025-12-31100 at the start220

Sales: 100.00 on 2016-12-31 to 219.97 on 2025-12-31, up 120%.

Profit

197

2016-12-31 to 2025-12-31100 at the start197

Profit: 100.00 on 2016-12-31 to 196.77 on 2025-12-31, up 97%.

Shares in issue

101

2016-12-31 to 2025-12-31100 at the start101

Shares in issue: 100.00 on 2016-12-31 to 101.13 on 2025-12-31, up 1%.

Sales is at 220, Profit is at 197, Shares in issue is at 101, against 100 in 2016.

Sales is at 220, Profit is at 197, Shares in issue is at 101, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100220
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
Profit, where the first year is 100197
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
Shares in issue, where the first year is 100101
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR